The new aspects of immunotherapy in prostate cancer

[1]  N. Yamamoto,et al.  Retraction Note to: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF , 2008, Cancer Immunology, Immunotherapy.

[2]  M. Bellone,et al.  Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy , 2012, Cancer Immunology, Immunotherapy.

[3]  M. Gulisano,et al.  Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay , 2011, Cancer Immunology, Immunotherapy.

[4]  N. Yamamoto,et al.  Retracted: Immunotherapy of HIV‐infected patients with Gc protein‐derived macrophage activating factor (GcMAF) , 2009, Journal of medical virology.

[5]  N. Yamamoto,et al.  Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. , 2008, Translational oncology.

[6]  N. Yamamoto,et al.  Retracted: Immunotherapy of metastatic breast cancer patients with vitamin D‐binding protein‐derived macrophage activating factor (GcMAF) , 2008, International journal of cancer.

[7]  H. Nagasawa,et al.  Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. , 2005, Anticancer research.

[8]  H. Kanetake,et al.  Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. , 2002, Journal of the National Cancer Institute.

[9]  H. Devaraj,et al.  Serum α-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix , 2000 .

[10]  H. Devaraj,et al.  Serum alpha-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix. , 2000, Cancer letters.

[11]  N. Yamamoto,et al.  Structurally well‐defined macrophage activating factor derived from vitamin D3‐binding protein has a potent adjuvant activity for immunization , 1998, Immunology and cell biology.

[12]  G. Poste,et al.  Production of C3 as a marker of lymphokine-mediated macrophage activation. , 1984, Cellular immunology.